Atrial fibrillation (AF) significantly increases the risk of stroke and, therefore, stroke
prevention is an essential component of the management for patients with AF. This requires …

Stroke prevention with appropriate thromboprophylaxis still remains central to the
management of atrial fibrillation (AF). Nonetheless, stroke risk in AF is not homogeneous …

Atrial fibrillation (AF) is the commonest sustained cardiac rhythm disorder, which is
associated with a substantial risk of mortality and morbidity arising from stroke and …

Optimal stroke prevention using oral anticoagulant (OAC) therapy is essential for the
management of patients with atrial fibrillation (AF) who are at increased risk of stroke, but …

Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice,
and confers a substantial risk of stroke and thromboembolism. Anticoagulation with warfarin …

Despite the clear net clinical benefit of oral anticoagulation (OAC) in atrial fibrillation (AF)
patients at risk for stroke, major bleeding events (especially intra-cranial bleeds) may be …

Atrial fibrillation (AF) patients are widely heterogeneous in terms of ischaemic stroke risk,
and several risk stratification schemes have been developed. We performed a prospective …

Stroke prevention is central to the management of patients with atrial fibrillation (AF). As
effective stroke prophylaxis essentially requires oral anticoagulants, an understanding of the …

Atrial fibrillation (AF) is one of major problems of the contemporary cardiology. Ischaemic
stroke is a common complication of the AF, and effective prophylaxis requires treatment with …

Despite the demonstrable success of oral anticoagulants in reducing the rate of stroke in
patients with atrial fibrillation, they continue to be seriously underutilized. Indications for their …